5Therasse P, Arbuck SG,Eisenhauer EA,et al. New guidelines to evaluate the response to treatment in solid tumors [J]. J Natl Cancer Inst,2000,92(3):205 --216.
6Burris 3rd HA, Moore M J, Andersen J, et al.Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreas cancer: a randomized trial [J]. J Clin Oncol,1997,15(13) :2403--2413.
7Bai YR, Wu GH, Guo WJ, et al. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic eancer-results of feasibility study [J]. World J Gastroenterol, 2003,9 ( 11 ):2561 -- 2564.
8Huguet F, Andre T, Hammel P, et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase Ⅱ and Ⅲ studies [J]. J Clin Oncol,2007,25(3) :326--331.
9Moureau-Zabotto L, Philip JM, Afchain P, et al.Concomitant administration of weekly oxaliplatin,fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a groupe coordinateur multidisciplinaire en oncologie phase ii study [J]. J Clin Oncol, 2008, 26 (7) : 1080-- 1085.
10Ryan DP, Niedzwiecki D,Hollis D,et al.Phase Ⅰ/Ⅱ study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: cancer and leukemia group B 89901 [J]. J Clin Oncol,2006,24(16):2557- 2562.
